Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Minghui Pharmaceutical Inc. Announces First Patient Dosing in Phase 1 Clinical Studies of Both the Antibody-Drug Conjugate Programs Targeting TROP-2 or B7-H3 Respectively, for Treatment of Advanced or Metastatic Solid Tumors 2023-06-20 18:30
Curocell announced encouraging updates on the next-generation anti-CD19 CAR-T, Anbalcabtagene-autoleucel at International Conference on Malignant Lymphoma (ICML) 2023 2023-06-20 08:01
Bergen Prepares to Host International Conference on Hansen's Disease Marking 150 Years Since the Discovery of the Leprosy Bacillus 2023-06-19 19:00
The Summit Forum on the Application and Construction of AGP in China Takes Place in Shenzhen 2023-06-19 16:00
MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE 2023-06-17 07:04
The U.S. FDA Approved the Phase I/II Clinical Trial Application to Evaluate LBL-033, An Anti-MUC16/CD3 Bispecific Antibody Developed by Leads Biolabs, in Advanced Solid Tumors Including Ovarian Cancer 2023-06-16 22:01
SeekIn paves the way for cancer early detection in low- and middle-income countries 2023-06-16 21:00
Cholesgen to enter into a drug discovery collaboration and licensing option agreement in hypercholesterolemia with AstraZeneca 2023-06-16 18:00
Singleron launches two new instruments to further standardize single cell analysis workflow 2023-06-16 16:18
BrightMD Fair China 2023 Concludes Successfully, Fostering Collaborative Synergies in Shenzhen 2023-06-15 21:02
Vatech's EzRay Air Series Continues to achieve Record-Breaking Sales Performance Worldwide 2023-06-15 21:00
Mabwell Announces the U.S. FDA approval of 9MW3811 for IND 2023-06-15 21:00
Mabwell Publishes the Preclinical Study Results on Its Nectin-4 Targeting ADC in A Well-known AACR Journal 2023-06-15 21:00
China Jo-Jo Drugstores Reports Fiscal Year 2023 Financial Results 2023-06-15 21:00
Addentax Group Corp. in Advanced Talks to Acquire Partial Stake in RMB 6 Billion-Valued Recombinant Protein Drugs and Antibody Drugs Bio-pharmaceutical Company, Shanghai Bao Pharmaceutical Company Limited 2023-06-15 20:00
FDA Approved Utidelone Injectable (UTD1) Phase 2/3 Multi-National Clinical Trial for Non-Small Cell Lung Cancer 2023-06-15 19:31
Springer Nature to Join Seegene's OneSystem™ Business as Strategic Partner 2023-06-15 19:00
Telix Briefing: Innovation in Urology to Feature Key Opinion Leaders in Prostate and Kidney Cancer 2023-06-15 19:00
Nippon Express Europe Exhibits at LogiPharma 2023 for First Time 2023-06-15 14:00
111, Inc. Announces First Quarter 2023 Unaudited Financial Results 2023-06-15 13:22
1 73 74 75 76 77 431